J. Michael Ellis
4Patents
1h-index
53Co-inventors
40Inventor score
Filing activity: Dec 1, 2015 → Oct 8, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10508108B2 | Tricyclic compounds as inhibitors of mutant IDH enzymes | Chemistry; Metallurgy | 1 | Active |
| US11161854B2 | Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11174248B2 | Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10442819B2 | Tricyclic compounds as inhibitors of mutant IDH enzymes | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.